PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Ivabradine - Heart failure
PAD Profile : Ivabradine - Heart failure
Keywords :
NICE
Brand Names Include :
Procoralan
Traffic Light Status
Status 1 of 1.
Status :
Blue
Important
Formulations :
- Tablets
Important Information :
Restricted to initiation by cardiology only. Transfer of prescribing to primary care only after initiation and at least the first month supply from the specialist.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Eplerenone
- Sacubitril/valsartan
- Digoxin
- Spironolactone
- Co-amilozide (Amiloride hydrochloride/hydrochlorot
- Dapagliflozin
- Empagliflozin
- Metolazone
- Ramipril
- Captopril
- Enalapril maleate
- Lisinopril
- Perindopril erbumine
- Bisoprolol fumarate
- Carvedilol
- Nebivolol
- Candesartan cilexetil
- Losartan potassium
- Valsartan
- Prazosin hydrochloride
- Hydralazine hydrochloride
- Acetazolamide
- Levosimendan
- Enoximone
- Milrinone lactate
Other Indications
Additional Documents
Type
Document
Review Date
Shared Care
01 January 2016
Shared Care
01 January 2016
Committee Recommendations
Date
Committee Name
Narrative
30 January 2013
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Ivabradine is recommended by the PCN in line with NICE guidance. It would be considered to be suitable as Amber* and an information sheet will be produced for discussion at the PCN in February/ March 2013.
Associated BNF Codes
02. Cardiovascular System
02.06.03. Other antianginal drugs